![Harish Shantharam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harish Shantharam
Directeur Financier/CFO chez
ALX ONCOLOGY HOLDINGS INC.
Fortune : 148 200 $ au 31/05/2026
Profil
Harish Shantharam currently works at ALX Oncology Holdings, Inc., as Chief Financial Officer from 2025.
Mr. Shantharam also formerly worked at CymaBay Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024, Gilead Sciences, Inc., as Vice President-Global Commercial Finance from 2011 to 2022, and Amgen, Inc., as Head-Business Development from 2004 to 2011.
Mr. Shantharam received his graduate degree from The University of Texas at Arlington and Masters Business Admin degree from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 78 000 ( 0,06% ) | 148 200 $ | 31/05/2026 |
Postes actifs de Harish Shantharam
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur Financier/CFO | 21/01/2025 |
Anciens postes connus de Harish Shantharam
| Sociétés | Poste | Fin |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Directeur Financier/CFO | 22/03/2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/11/2011 |
Formation de Harish Shantharam
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
